Alpine Woods Capital Investors, LLC Myriad Genetics Inc Transaction History

Alpine Woods Capital Investors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$9.78 - $29.53 $77,262 - $233,287	-7,900 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$20.93 - $35.1 $14,651 - $24,570	-700 Reduced 8.14%	7,900 $215,000
Q3 2019 Nov 01, 2019	SELL	$22.08 - $47.08 $4,416 - $9,416	-200 Reduced 2.27%	8,600 $246,000
Q2 2019 Aug 05, 2019	SELL	$22.67 - $35.0 $317,380 - $490,000	-14,000 Reduced 61.4%	8,800 $244,000
Q1 2019 May 06, 2019	BUY	$26.93 - $34.7 $209,784 - $270,313	7,790 Added 51.9%	22,800 $757,000
Q3 2018 Nov 08, 2018	BUY	$37.57 - $50.34 $563,925 - $755,603	15,010 New	15,010 $690,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.